Raab & Moskowitz Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Raab & Moskowitz Asset Management's XBI Position: Q1 2015 in Review
Raab & Moskowitz Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2015, closing a stake of 486 shares — an estimated $30K sold.
Raab & Moskowitz Asset Management first reported a position in XBI in Q4 2014 and held it in 1 quarter. The position peaked at $30K in Q4 2014. 180 funds tracked by Wall St. Rank hold XBI as of Q1 2015.
- Raab & Moskowitz Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2015 after selling out during the quarter.
- Raab & Moskowitz Asset Management sold 486 State Street SPDR S&P Biotech ETF shares in Q1 2015, an estimated $30K.
- Raab & Moskowitz Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2014 and held it in 1 quarter.
- Raab & Moskowitz Asset Management's State Street SPDR S&P Biotech ETF position peaked at $30K in Q4 2014.
- 180 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2015.
Based on Raab & Moskowitz Asset Management's 13F filing for Q1 2015, filed 12 May 2015.